Neurexis Therapeutics

About:

Neurexis Therapeutics develops therapeutic peptide for post-insult neuroprotection.

Website: https://neurexistherapeutics.com/

Top Investors: VIC Technology Venture Development, National Institute of Neurological Disorders and Stroke, Colorado Office of Economic Development and International Trade

Description:

Neurexis Therapeutics provides stroke and cardiac arrest treatments. They offer treatments for cerebral ischemia, sickle cell anemia, congenital heart defects, vascular surgery, and pre-existing coronary disease.